Health and Healthcare
Major Biotechs See Increased Short Interest Bets
Published:
Last Updated:
The short interest data are out for the July 15 settlement date. Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside. In fact, a cure or incredible new breakthrough in cancer or Alzheimer’s disease will be worth more than any risks from Brexit or political rhetoric from the campaign trail.
FDA rulings can make or break the biotech sector, and short sellers and mega-bulls often go to war against each other in these companies. After all, if a single failed clinical trial can mean disaster for a stock, then some short sellers can argue for a stock implosion down the road.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The July 15 short interest data have been compared with the previous report, and short interest increased across many of these selected biotech stocks.
Amgen Inc. (NASDAQ: AMGN) saw its short interest rise ever so slightly to 7.82 million shares from the previous level of 7.80 million. Shares closed most recently at $167.67, in a 52-week trading range of $130.09 to $181.81.
Biogen Inc. (NASDAQ: BIIB) had its short interest increase to 2.58 million shares from the previous 2.49 million. The stock closed Tuesday at $287.04, within a 52-week range of $223.02 to $338.51.
Celgene Corp. (NASDAQ: CELG) short interest for this settlement date decreased to 7.13 million shares from the previous 8.31 million. Shares closed most recently at $106.18, in a 52-week range of $92.98 to $136.40.
Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest decrease to 21.41 million shares from 22.21 million in the previous period. Shares closed Tuesday at $81.05, in a 52-week trading range of $77.92 to $120.37.
MannKind Corp. (NASDAQ: MNKD) saw its short interest increase to 86.15 million shares. The previous reading was 85.96 million. Shares closed most recently at $0.99, in a 52-week trading range of $0.64 to $4.98.
Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) short interest increased to 6.35 million, compared to the previous level of 4.74 million. Shares closed most recently at $126.65, in a 52-week range of $110.56 to $205.29.
100 Million Americans Are Missing This Crucial Retirement Tool
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
